Efficacy and Safety of Ghrelin Agonists in Patients with Diabetic Gastroparesis: A Systematic Review and Meta-Analysis

BACKGROUND/AIMS: Ghrelin agonists are emerging prokinetic agents for treating gastroparesis. Although recent clinical trials have demonstrated their efficacy in patients with diabetic gastroparesis (DG), the impact of such agents on symptoms and gastric dysmotility remains unclear. We performed a sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Seung Wook, Chun, Jaeyoung, Kim, Jihye, Lee, Jooyoung, Lee, Hyun Jung, Chung, Hyunsoo, Cho, Soo-Jeong, Im, Jong Pil, Kim, Sang Gyun, Kim, Joo Sung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492501/
https://www.ncbi.nlm.nih.gov/pubmed/31816671
http://dx.doi.org/10.5009/gnl19103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492501/
https://www.ncbi.nlm.nih.gov/pubmed/31816671
http://dx.doi.org/10.5009/gnl19103

Ejemplares similares